ClinicalTrials.gg
TerminatedNCT04642612CBF-TCDUpdated Sep 16, 2021

Cerebral Blood Flow Evaluation With Trancranial Doppler After Interscalene Nerve Block

An observational study in Regional Anesthesia, Horner Syndrome and Cerebral Blood Flow, sponsored by Stanford University. Terminated at 1 site in United States. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-09-16.

Sponsored by Stanford University · Observational

Why this study was terminated
Study not properly designed for outcome measure

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
10
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The purpose of this study is to assess cerebral blood flow velocity (CBFV) following regional anesthesia for shoulder surgery. The results of this study will help to further understand the physiologic effect of the interscalene nerve block on cerebral blood flow.

Read the detailed description

Traditionally, cerebral blood flow (CBF) is believed to decline when mean arterial pressure (MAP) is below the lower limit of cerebral autoregulation. Cerebral blood flow autoregulation refers to the capacity of the central nervous system to maintain blood flow within a wide range of mean arterial blood pressure.

The habitual thinking is that the brain is perfused merely dependent by the blood pressure and that above or below the limits of cerebral autoregularion CBF is pressure passive. Despite this notion, there is evidence showing that parameters other than MAP influence cerebral hemodynamics independent of cerebral autoregulation. One of the physiologic processes that contribute to CBF regulation is cardiac output (CO). However, exactly how an alteration in CO, in the face of a stable blood pressure, leads to a change in CBF is not entirely clear.

One of the suggested mechanisms in play is the sympathetic nervous system (SNS)-mediated vasoconstriction of extracranial and proximal intracranial vessels. Cerebral arteries are abundantly innervated by sympathetic nerve fibers originating from the superior cervical ganglion. Studies have shown that CBF reduction is attenuated by pharmacologic blockade or extirpation of the cervical sympathetic chain.

The anesthetic protocol for patients undergoing major shoulder surgery include an interscalene nerve block (ISNB) combined with general anesthesia in the sitting position. The ISNB involves injecting local anesthetic at the level of the cervical spinal roots. One of the most common side effects encountered after ISNB is Horner syndrome, which is characterized by ptosis, myosis, and enopthalmia. Horner's syndrome results from the diffusion of the local anesthetic solution to the ipsilateral sympathetic cervical chain (stellate ganglion). The presence of Horner's syndrome indicates spread of local anesthetic to the sympathetic chain.

Whether this degree of sympatholytic following interscalene block is associated with an observable change in CBF is unknown. Studies in baboon have shown that cervical surgical sympathectomy maintained CBF in the face of hemorrhagic hypotension and CBF did not decrease until MAP was 35% of the baseline value. These results suggest that sympathectomy induced by the block of the sympathetic chain by the local anesthetic injected for the ISNB might alter CBF. Therefore, the aim of our study is to evaluate the effect of unilateral interscalene nerve block on CBF by measuring CBF velocity non-invasively with Transcranial doppler (TCD).

02

Conditions studied

  • Regional Anesthesia
  • Horner Syndrome
  • Cerebral Blood Flow
03

In context

Lead sponsor

Stanford University is the lead sponsor of 2,170 studies on the registry; 431 are open to participants now.

Of its 267 completed or terminated interventional studies of FDA-regulated products, 207 (78%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients undergoing orthopedic surgery with an indication for preoperative insertion of interscalene nerve block, aged 18-85 years old, and give consent to participating in study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing orthopedic surgery and with an indication for preoperative insertion of interscalene nerve block
  • 18-85 years old
  • Give consent to participate in study

Exclusion criteria

Exclusion Criteria:

  • Cannot give consent
  • Patients who are clinically unstable or require urgent/emergent intervention
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
10 participants (actual)
Patient registry
No

Groups and cohorts

  • Treatment Arm

    Patients ages 18-85 years old presenting with orthopedic shoulder surgery with indication to receive preoperative insertion of interscalene nerve block.

    Device: TCD Measurement

Interventions

  • DeviceTCD Measurement

    CBFV measurements will be acquired continuously with the patient supine and the head neutral. Analysis of CBFV measurements will be undertaken at 3 timepoints: 1. Patient awake and supine in the holding area 2. After sedation 3. After interscalene nerve block

06

What researchers measure

Primary outcomes

  1. Cerebral Blood Flow Velocity before and after interscalene nerve block

    The TCD automatically measures blood flow velocity in the main cerebral arteries of the circle of Willis. We will target the MCA which is the closest to the temporal bone therefore the most easily accessible for insonation and monitoring. We will do a bilateral monitoring.

    Time frame: baseline, after 30 minutes

Secondary outcomes

  1. Systolic, diastolic, mean blood pressure changes before and after interscalene nerve block

    Will be measured before/during/after interscalene nerve block placement

    Time frame: baseline, after 30 minutes

  2. Heart Rate

    Will be measured before/during/after interscalene nerve block placement

    Time frame: baseline, after 30 minutes

  3. Respiratory Rate changes before and after interscalene nerve block

    Will be measured before/during/after interscalene nerve block placement

    Time frame: baseline, after 30 minutes

  4. EtCO2 changes before and after interscalene nerve block

    Will be measured before/during/after interscalene nerve block placement

    Time frame: baseline, after 30 minutes

  5. SpO2 changes before and after interscalene nerve block

    Will be measured before/during/after interscalene nerve block placement

    Time frame: baseline, after 30 minutes

  6. Type of local anesthetic

    Local anesthetic characteristics will be collected after interscalene block placement.

    Time frame: 30 minutes after the nerve block

  7. Position of the needle on the cervical trunk for interscalene nerve block

    Needle position for interscalene nerve block insertion will be assessed at the time of interscalene block placement

    Time frame: Baseline

  8. Volume of of local anesthetic

    Local anesthetic characteristics will be collected after interscalene block placement.

    Time frame: 30 minutes after the nerve block

  9. Concentration of local anesthetic

    Local anesthetic characteristics will be collected after interscalene block placement.

    Time frame: 30 minutes after the nerve block

07

Study locations

1 site
  • Stanford University School of Medicine
    Stanford, California 94304, United States
08

References and documents

Publications

  • Meng L, Hou W, Chui J, Han R, Gelb AW. Cardiac Output and Cerebral Blood Flow: The Integrated Regulation of Brain Perfusion in Adult Humans. Anesthesiology. 2015 Nov;123(5):1198-208. doi: 10.1097/ALN.0000000000000872. PubMed 26402848 ↗
  • Drummond JC. Cardiac Output: The Neglected Stepchild of the Cerebral Blood Flow Physiology Family. J Neurosurg Anesthesiol. 2020 Apr;32(2):93-94. doi: 10.1097/ANA.0000000000000677. No abstract available. PubMed 31972625 ↗
  • ter Laan M, van Dijk JM, Elting JW, Staal MJ, Absalom AR. Sympathetic regulation of cerebral blood flow in humans: a review. Br J Anaesth. 2013 Sep;111(3):361-7. doi: 10.1093/bja/aet122. Epub 2013 Apr 24. PubMed 23616589 ↗
  • Fitch W, MacKenzie ET, Harper AM. Effects of decreasing arterial blood pressure on cerebral blood flow in the baboon. Influence of the sympathetic nervous system. Circ Res. 1975 Nov;37(5):550-7. doi: 10.1161/01.res.37.5.550. PubMed 153 ↗
  • Seltzer JL. Hoarseness and Horner's syndrome after interscalene brachial plexus block. Anesth Analg. 1977 Jul-Aug;56(4):585-6. doi: 10.1213/00000539-197707000-00033. No abstract available. PubMed 560150 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2021 to primary completion in May 2021, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 2, 2020
First posted
Nov 24, 2020
StartActual
Mar 4, 2021
Primary completionActual
May 19, 2021
CompletionActual
Jul 30, 2021
Last update
Sep 16, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 16, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04642612
Responsible party
Anna Maria Bombardieri (Clinical Assistant Professor of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford University) — Principal investigator
First posted
Nov 24, 2020
Start date
Mar 4, 2021
Primary completion
May 19, 2021
Completion
Jul 30, 2021
Last update
Sep 16, 2021

Study contacts

Anna Maria Bombardieri, MD, PhD
principal investigator · Stanford University

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion